ReviewMedical oncology (Northwood, London, England)2026

Making Zolbetuximab deliverable in practice: multidisciplinary management of nausea, vomiting, gastritis, and hypoalbuminemia in first-line CLDN18.2-positive, HER2-negative gastric/GEJ adenocarcinoma.

Tamotsu Sagawa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.